FeraMAX® Celebrates a Decade as Top Iron Supplement in Canada
FeraMAX® Celebrates a Decade of Excellence
BioSyent Inc. is delighted to share exciting news: its FeraMAX® brand has been recognized as the top iron supplement in Canada for a remarkable tenth consecutive year. This honor is based on a respected national survey that asked pharmacists and physicians across Canada for their recommendations. The consistent recognition of FeraMAX® is not just a win for the brand; it reflects the trust that healthcare professionals place in its ability to support iron health.
Importance of the Survey
The annual OTC Counselling and Recommendations Survey serves as a critical benchmark in the pharmaceutical industry. Conducted by EnsembleIQ Research and Innovation across several pertinent platforms, this survey gauges the counseling patterns of healthcare providers regarding over-the-counter products. It’s a vital tool that reveals how pharmacists and physicians advise their patients on non-prescription products, highlighting the role of FeraMAX® in popular health solutions.
Perceptions of Healthcare Professionals
René Goehrum, BioSyent's President and CEO, expressed gratitude for the ongoing trust that Canadian healthcare professionals have in FeraMAX®. He emphasizes the commitment of BioSyent to innovate and expand its range of FeraMAX® offerings tailored to address and prevent iron deficiency at every stage of life. This dedication is part of what makes FeraMAX® the leading choice for iron supplementation in Canada.
Innovative Solutions Offered by FeraMAX®
The FeraMAX® brand stands out due to its unique Polydextrose-Iron Complex (PDIC) formulation, which is patented and crafted to provide effective and convenient daily iron dosages. The product line includes:
- FeraMAX® Pd Therapeutic 150: An oral supplement specifically designed for treating iron deficiency anemia.
- FeraMAX® Pd Powder 15: A powder supplement aimed at making iron therapy more accessible for children.
- FeraMAX® Pd Maintenance 45: Launched recently, this product is designed to help maintain healthy iron levels and to prevent deficiency.
The family of FeraMAX® products demonstrates the company's commitment to innovative solutions that cater to the diverse needs of various age groups and lifestyles.
About BioSyent Inc.
BioSyent Inc. operates on the TSX Venture Exchange under the ticker symbol “RX”. This Canadian pharmaceutical company prides itself on its growth-oriented approach, focusing on in-licensing or acquiring innovative healthcare products that have proven effective in improving patient lives. With a focus on supporting healthcare professionals, BioSyent markets its products through numerous channels, making them accessible to Canadians in need of effective health solutions.
Market Presence and Performance
As of now, BioSyent has 11,222,517 common shares outstanding, reflecting its stable market presence. The company continues to engage with its community and specialty businesses to promote the health benefits associated with its products, especially the acclaimed FeraMAX® supplements. To stay updated on the company’s financial situation and stock performance, interested parties can visit financial information platforms.
Frequently Asked Questions
What makes FeraMAX® the top iron supplement in Canada?
FeraMAX® has been recognized for a decade due to its effective formulation and strong recommendations from healthcare professionals.
Who conducted the survey that recognized FeraMAX®?
The survey was conducted by EnsembleIQ Research through platforms that focus on pharmacy practice and business, highlighting the importance of healthcare provider opinions.
What is the significance of the Polydextrose-Iron Complex?
This patented formulation in FeraMAX® products is designed for effective iron absorption, making it unique among iron supplements.
How does BioSyent support healthcare professionals?
BioSyent provides marketing and access to innovative healthcare products, thus supporting practitioners in delivering quality care to their patients.
How can I contact BioSyent for more information?
You can reach Mr. René C. Goehrum, President and CEO, via email at investors@biosyent.com or call 905-206-0013 for any inquiries.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.